Trevi Therapeutics Inc (TRVI)
4.10
+0.10
(+2.50%)
USD |
NASDAQ |
Dec 26, 11:16
Trevi Therapeutics Free Cash Flow: -35.12M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Aptevo Therapeutics Inc | -23.28M |
| Keros Therapeutics Inc | -142.50M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
| iBio Inc | -16.93M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.556M |
| Cash from Investing (Quarterly) | 7.667M |
| Cash from Financing (Quarterly) | 4.978M |
| Free Cash Flow Per Share (Quarterly) | -0.0944 |
| Free Cash Flow Yield | -8.54% |